Publication | Open Access
FOLFOX-4 as second-line therapy after failure of gemcitabine and platinum combination in advanced gall bladder cancer patients
25
Citations
12
References
2015
Year
FOLFOX-4 is an effective and well-tolerated regimen as a second-line treatment in advanced gall bladder cancer patients. Further studies are required, especially in the Indian subcontinent.
| Year | Citations | |
|---|---|---|
Page 1
Page 1